10x Genomics/TXG

$46.69

-0.99%
-
1D1W1MYTD1YMAX

About 10x Genomics

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.

Ticker

TXG

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Serge Saxonov

Employees

1,259

Headquarters

Pleasanton, United States

10x Genomics Metrics

BasicAdvanced
$5.42B
Market cap
-
P/E ratio
-$2.18
EPS
1.92
Beta
-
Dividend rate

What the Analysts think about 10x Genomics

Analyst Ratings

Majority rating from 16 analysts.
Buy

Price Targets

Average projection from 14 analysts.
25.29% upside
High $70.00
Low $30.00
$46.69
Current price
$58.50
Average price target

10x Genomics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-26.59% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$183.9M
19.73%
Net income
$-48.9M
-47.36%
Profit margin
-26.59%
-56.04%

10x Genomics Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 14.4%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.44
-$0.53
-$0.79
-$0.41
-
Expected
-$0.37
-$0.40
-$0.46
-$0.36
-$0.51
Surprise
17.7%
31.31%
71.91%
14.4%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell 10x Genomics stock

Buy or sell 10x Genomics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing